Protalix Biotherapeutics, Inc. (Amex: PLX) today announced the completion of its New Drug Application submission with the U.S. FDA for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE